-
CYTK Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Cytokinetics (CYTK)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 47.26 mm | 47.26 mm | 47.26 mm | 47.26 mm | 47.26 mm | 47.26 mm |
Cash burn (monthly) | 47.75 mm | 4.40 mm | 46.93 mm | 43.72 mm | 33.83 mm | 33.70 mm |
Cash used (since last report) | 192.06 mm | 17.70 mm | 188.77 mm | 175.84 mm | 136.08 mm | 135.53 mm |
Cash remaining | -144.80 mm | 29.56 mm | -141.51 mm | -128.58 mm | -88.82 mm | -88.27 mm |
Runway (months of cash) | -3.0 | 6.7 | -3.0 | -2.9 | -2.6 | -2.6 |
13F holders | Current |
---|---|
Total holders | 354 |
Opened positions | 45 |
Closed positions | 48 |
Increased positions | 143 |
Reduced positions | 94 |
13F shares | Current |
---|---|
Total value | 6.38 tn |
Total shares | 143.51 mm |
Total puts | 2.42 mm |
Total calls | 4.59 mm |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 15.25 mm | $805.35 bn |
FMR | 12.09 mm | $638.58 bn |
Vanguard | 11.76 mm | $621.01 bn |
T. Rowe Price Investment Management | 9.69 mm | $511.63 mm |
Wellington Management | 7.77 mm | $410.52 bn |
STT State Street | 6.46 mm | $341.00 bn |
BAC Bank of America | 4.83 mm | $254.99 bn |
T. Rowe Price | 3.16 mm | $167.11 mm |
Eastern Capital | 3.06 mm | $64.35 mm |
Geode Capital Management | 2.85 mm | $150.43 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Jan 25 | Fady Ibraham Malik | Common Stock | Sell | Dispose S | No | No | 45.92 | 2,000 | 91.84 k | 116,071 |
21 Jan 25 | Fady Ibraham Malik | Common Stock | Option exercise | Acquire M | No | No | 10.6 | 2,000 | 21.20 k | 118,071 |
21 Jan 25 | Fady Ibraham Malik | NQSO Common Stock | Option exercise | Dispose M | No | No | 10.6 | 2,000 | 21.20 k | 37,105 |
7 Jan 25 | Fady Ibraham Malik | Common Stock | Sell | Dispose S | No | No | 49.32 | 2,000 | 98.64 k | 116,071 |
7 Jan 25 | Fady Ibraham Malik | Common Stock | Option exercise | Acquire M | No | No | 10.6 | 2,000 | 21.20 k | 118,071 |
7 Jan 25 | Fady Ibraham Malik | NQSO Common Stock | Option exercise | Dispose M | No | No | 10.6 | 2,000 | 21.20 k | 39,105 |
2 Jan 25 | Henderson John T | Common Stock | Grant | Acquire A | No | No | 48.93 | 434 | 21.24 k | 48,987 |
2 Jan 25 | Wysenski Nancy | Common Stock | Grant | Acquire A | No | No | 48.93 | 127 | 6.21 k | 23,115 |
2 Jan 25 | Wierenga Wendall | Common Stock | Grant | Acquire A | No | No | 48.93 | 127 | 6.21 k | 24,686 |